BlackRock Advisors’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $607K | Buy |
16,027
+2,987
| +23% | +$113K | ﹤0.01% | 2045 |
|
|
2016
Q3 | $492K | Buy |
13,040
+730
| +6% | +$27.5K | ﹤0.01% | 2129 |
|
|
2016
Q2 | $217K | Buy |
12,310
+1,608
| +15% | +$28.3K | ﹤0.01% | 2516 |
|
|
2016
Q1 | $130K | Buy |
10,702
+649
| +6% | +$7.88K | ﹤0.01% | 2737 |
|
|
2015
Q4 | $245K | Sell |
10,053
-4,185
| -29% | -$102K | ﹤0.01% | 2431 |
|
|
2015
Q3 | $253K | Buy |
14,238
+1,487
| +12% | +$26.4K | ﹤0.01% | 2557 |
|
|
2015
Q2 | $225K | Buy |
12,751
+5,775
| +83% | +$102K | ﹤0.01% | 2693 |
|
|
2015
Q1 | $219K | Buy |
6,976
+892
| +15% | +$28K | ﹤0.01% | 2593 |
|
|
2014
Q4 | $178K | Sell |
6,084
-190
| -3% | -$5.56K | ﹤0.01% | 2672 |
|
|
2014
Q3 | $130K | Sell |
6,274
-20,361
| -76% | -$422K | ﹤0.01% | 2828 |
|
|
2014
Q2 | $660K | Sell |
26,635
-6,101
| -19% | -$151K | ﹤0.01% | 1774 |
|
|
2014
Q1 | $694K | Buy |
32,736
+16,210
| +98% | +$344K | ﹤0.01% | 1787 |
|
|
2013
Q4 | $297K | Buy |
+16,526
| New | +$297K | ﹤0.01% | 2386 |
|